Drug-Drug Interactions in Elderly Patients with Potentially Inappropriate Medications in Primary Care, Nursing Home and Hospital Settings: A Systematic Review and a Preliminary Study

Archive ouverte

Bories, Mathilde | Bouzillé, Guillaume | Cuggia, Marc | Le Corre, Pascal

Edité par CCSD ; MDPI -

International audience. Drug-drug interactions (DDI) occurring with potentially inappropriate medications (PIM) are additional risk factors that may increase the inappropriate character of PIM. The aim of this study was (1) to describe the prevalence and severity of DDI in patients with PIM and (2) to evaluate the DDI specifically regarding PIM. This systematic review is based on a search carried out on PubMed and Web-of-Science from inception to June 30, 2020. We extracted data of original studies that assessed the prevalence of both DDI and PIM in elderly patients in primary care, nursing home and hospital settings. Four hundred and forty unique studies were identified: 91 were included in the qualitative analysis and 66 were included in the quantitative analysis. The prevalence of PIM in primary care, nursing home and hospital were 19.1% (95% confidence intervals (CI): 15.1-23.0%), 29.7% (95% CI: 27.8-31.6%) and 44.6% (95% CI: 28.3-60.9%), respectively. Clinically significant severe risk-rated DDI averaged 28.9% (95% CI: 17.2-40.6), in a hospital setting; and were approximately 7-to-9 lower in primary care and nursing home, respectively. Surprisingly, only four of these studies investigated DDI involving specifically PIM. Hence, given the high prevalence of severe DDI in patients with PIM, further investigations should be carried out on DDI involving specifically PIM which may increase their inappropriate character, and the risk of adverse drug reactions.

Suggestions

Du même auteur

Leveraging national claim and hospital big data integration: a cohort study on a statin-drug interaction use case.

Archive ouverte | Bannay, Aurélie | CCSD

International audience

Leveraging Clinical Data Warehouses to Measure Impact of Update Prescription Guidelines of Polyvalent Immunoglobulins in 2018 in France

Archive ouverte | Pierre-Jean, Morgane | CCSD

International audience. In France and in other countries, we observed a significant growth in human polyvalent immunoglobulins (PvIg) usage. PvIg is manufactured from plasma collected from numeral donors, and its pr...

Drug-Drug Interactions with Oral Anticoagulants as Potentially Inappropriate Medications: Prevalence and Outcomes in Elderly Patients in Primary Care and Hospital Settings

Archive ouverte | Bories, Mathilde | CCSD

International audience. Direct oral anticoagulants and vitamin K antagonists are considered as potentially inappropriate medications (PIM) in several situations according to Beers Criteria. Drug-drug interactions (D...

Chargement des enrichissements...